A study by Louise C. Walter, M.D., of San Francisco Veterans Affairs Medical Center, California, and colleagues sought to quantify 5-year downstream outcomes following an abnormal prostate-specific antigen (PSA) screening result of 4.0 ng/mL or more, in older men...
Комментариев нет:
Отправить комментарий